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Introduction
The two major forms of motoneuron disease, proximal spinal 
muscular atrophy (SMA) and amyotrophic lateral sclerosis, are 
caused by selective cell death of motoneurons. Among the 
mecha  nisms that are thought to play a central role are cell-
autonomous mechanisms like oxidative stress and mitochondrial 
dysfunction (Pasinelli and Brown, 2006), but also nonautono-
mous processes such as dysregulated signaling from neighbor-
ing glial cells and contacting neurons (Boillee et al., 2006; 
Urushitani et al., 2006). Such mechanisms have been studied 
in great detail for amyotrophic lateral sclerosis (Bruijn et al., 
2004). In contrast, much less is known for proximal SMA, the 
most common form of motoneuron disease in children and 
young adults (Crawford and Pardo, 1996; Swash and Desai, 
2000; Talbot and Davies, 2001; Iannaccone et al., 2004). This 
disease is caused by homozygous loss or mutations in the telo-
meric copy (SMN1) of the survival of motor neuron gene (SMN; 
Lefebvre et al., 1995) on human chromosome 5q13. Whereas the 
SMN1 gene allows expression of a functionally intact full-
length protein, most of the transcripts from the SMN2 gene code 
for a truncated protein lacking the functionally important 
  domains at the C terminus that are encoded by exon 7 (Lorson 
et al., 1999; Monani et al., 1999). Nevertheless, low expression 
of full-length Smn protein from the SMN2 gene occurs, but 
this is not suffi  cient for compensating the defect caused by 
SMN1 loss, thus leading to motoneuron disease in humans. 
In contrast to humans, mice carry only one Smn gene, and the 
homozygous knockout of the Smn gene in mice is lethal in early 
development, even before blastocysts are formed (Schrank 
et al., 1997).
The Smn gene is ubiquitously expressed, thus raising the 
question of how reduced levels of this protein lead to specifi  c 
motoneuron disease. Smn plays a role in the assembly and in 
recycling of spliceosomal uridine-rich small nuclear RNPs 
(Meister et al., 2001; Pellizzoni et al., 2002). Dysfunction of 
such processes should lead to severe defects in all cell types. 
The clinical phenotype of patients with SMA indicates that low 
levels of SMN protein, both in the full-length and the truncated 
form lacking the exon 7–encoded domains, are suffi  cient for de-
velopment, survival, and function of most types of cells, but not 
for motoneurons. It has therefore been hypothesized that moto-
neurons are more vulnerable, possibly because they are among 
the biggest cells in the body and their need for proper mRNA 
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expression, processing, and translation is probably higher than 
in other cell types (Monani, 2005). This hypothesis is supported 
by the observation that injection of assembled small nuclear 
RNP complexes into early Smn-defi  cient zebrafi  sh embryos can 
rescue defects in motoneurons (Winkler et al., 2005).
A mouse model for SMA has been generated by introduc-
ing the human SMN2 into a mouse Smn null background (Monani 
et al., 2000). The phenotype of these mice closely resembles 
that of humans. These mice develop severe paralysis within a few 
days after birth and normally die between postnatal day 1 and 5. 
Surprisingly, the loss of motoneuron cell bodies at late stages of 
the disease does not exceed 20%, suggesting that most moto-
neurons develop normally during embryogenesis and that dis-
ease becomes apparent before the majority of motoneurons are 
lost. Survival of spinal motoneurons that are isolated from 
Smn
−/−; SMN2 embryos does not differ from control moto-
neurons (Smn
+/+; SMN2). However, they exhibit a specifi  c defect 
in axon elongation that correlates with a defect in β-actin mRNA 
translocation to distal axons (Rossoll et al., 2003).
To study the underlying pathomechanism in Smn-defi  cient 
motoneurons, we have analyzed the functional consequences of 
Smn defi  ciency in growth cones. Smn-defi  cient motoneurons 
show defects in spontaneous excitability, and these defects corre-
late with reduced integration of voltage-gated Ca
2+ channels 
(VGCCs) into axonal growth cones. Treatment with cAMP in-
creases Smn levels in Smn
−/−; SMN2 motoneurons and leads to 
restoration of the morphological and functional defi  cits in axons 
and axon terminals. These fi  ndings indicate that reduced excit-
ability in growth cones contributes to the disease phenotype. 
This defect could lead to disturbances of active zones in the 
presynapse, causing reduced transmitter release at the motor 
endplate that, in turn, could contribute to motoneuron malfunction 
and degeneration in SMA.
Results
Spontaneous excitability is reduced 
in cultured Smn-deﬁ  cient motoneurons
In isolated embryonic Smn
−/−; SMN2 motoneurons, trans-
location of β-actin mRNA to distal axons and growth cones is 
disturbed (Rossoll et al., 2003). To investigate the functional 
consequences of Smn defi  ciency in axon terminals, we mea-
sured spontaneous excitability in motoneurons that were iso-
lated from embryonic day (E) 14 of control and Smn
−/−; SMN2 
mutant mouse embryos, and cultured them on laminin-111. 
The cultured neurons were loaded with Fura-2, a Ca
2+-binding 
fl  uorescent dye (Fig. 1 A, top left) and analyzed over periods 
of 7.5 min at 3, 4, 5, and 7 d in culture (Fig. 1 A, bottom left). 
In parallel to these measurements, motoneuron survival in the 
presence of brain-derived and ciliary neurotrophic factor (10 ng/ml 
each) was determined. No difference was observed between 
Smn-defi  cient and control motoneurons (Rossoll et al., 2003). 
In control Smn
+/+; SMN2 motoneurons that were cultured on 
laminin-111, spontaneous spikelike Ca
2+ transients were detect-
able that appeared synchronized in the cell body, dendrites, axons, 
and axonal growth cones, thus refl  ecting global spontaneous 
depolarization as described previously for developing neurons 
(Gu et al., 1994; Ciccolini et al., 2003). These transients could 
be blocked by 1 μM tetrodotoxin (TTX), indicating that they are 
triggered by opening of voltage-gated Na
+ channels (Fig. 1 A, 
top right). The addition of 0.3 and 1.0 μM ω-conotoxin MVIIA 
(CTX) inhibited these Ca
2+ transients, suggesting that N-type 
Ca
2+ channels are responsible for the Ca
2+ transients measured 
in these cultures (Figs. 1 A, bottom right; and S1 A, available at 
http://www.jcb.org/cgi/content/full/200703187/DC1).
The frequency of spikelike global spontaneous Ca
2+ tran-
sients within cell bodies and proximal axons of control moto-
neurons (Smn
+/+; SMN2) was highest on day 3, both in Smn
−/−; 
SMN2 and control motoneurons (Fig. 1 B). It declined after 
day 3 both in control and Smn
+/+; SMN2 motoneurons, confi  rming 
previous analyses (Gu and Spitzer, 1995), perhaps because the 
resting potential becomes more negative in embryonic moto-
neurons that are cultured for longer periods (Ziskind-Conhaim, 
1988). There was no difference in local transient frequency in 
the cell bodies and proximal axons of control and Smn
−/−; 
SMN2 motoneurons (Fig. 1 B).
We then investigated the frequency of such spikelike 
spontaneous transients in axons and growth cones (Fig. 1 C). 
At day 3 in culture, these transients were less frequent both in 
control and Smn
−/−; SMN2 motoneurons, indicating that not 
every transient spreads from the cell body and proximal axon to 
distal axons at this stage. At day 4, spikelike transient frequency 
was similar in cell bodies and distal axons in control motoneurons. 
At the same stage, the frequency of spikelike spontaneous 
Ca
2+ transients that reached the distal axons and growth cones 
was signifi  cantly reduced in Smn
−/−; SMN2 motoneurons (0.39 ± 
0.11 min
−1) in comparison to control Smn
+/+; SMN2 cells 
(0.83 ± 0.18 min
−1; P < 0.05). At days 5 and 7, the frequency 
of these spikelike transients further declined in Smn
−/−; SMN2 
motoneurons (Fig. 1 C). TTX and CTX also inhibited these 
spontaneous Ca
2+ transients on day 5 in culture (Fig. S1 A). 
The reduction of Ca
2+ transients was >50% at 0.3 μM CTX 
and increased to  80% at 1 μM CTX, indicating that infl  ux 
through VGCCs is the predominant source of these fast tran-
sients of cytosolic Ca
2+ (Fig. S1 A).
The time course of reduced spontaneous activity in distal 
axons and growth cones resembles that of axonal growth de-
fects in these cultures. As described previously (Rossoll et al., 
2003), axons in cultured Smn
−/−; SMN2 motoneurons are 
shorter at day 5. Surprisingly, signifi  cant differences in axon 
elongation (P < 0.05) are not detectable at earlier stages (Fig. 1, 
D, E, and J). Normally, between days 3 and 4, a doubling 
of axon length is observed in cultures of both control and 
Smn-defi  cient motoneurons, but the difference between Smn-
 defi  cient and control cells was not signifi  cant (Fig. 1, D, F, and 
K; P > 0.05). Only at days 5, 6, and 7 did reduced axon length 
become apparent in the Smn
−/−; SMN2 motoneurons (Fig. 1, D, 
G–I, and L–N).
These data suggest that defects in axonal Ca
2+ infl  ux 
  precede alterations in axon growth of cultured Smn
−/−; SMN2 
motoneurons. However, these defects occur late, starting at E14 
plus four additional days in culture (E14 + 4), at a developmental 
stage when maximal axon elongation has already occurred and 
motor endplate differentiation progresses in vivo.REDUCED EXCITABILITY IN SMN
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Local Ca
2+ transients in axonal growth 
cones are enhanced by laminin-211/221 
in Smn
−/−; SMN2 and control motoneurons
To follow the idea that axonal defects become apparent when 
Smn-defi  cient motoneurons get in contact with skeletal muscle, 
we investigated motoneurons on motor endplate–specifi  c forms 
of laminin (laminin-211/221). Previous papers have shown that 
neurite growth of motoneurons is reduced on this substrate (Porter 
et al., 1995; Greka et al., 2003). Furthermore, it has been shown 
that the β2 chain in laminin-221 interacts with the pore-forming 
(Cav) subunit of the N-type VGCC (Cav2.2; Nishimune et al., 
2004). Thus, presynaptic differentiation appears mediated 
through the direct interaction of laminin-221 with Cav2.2 channels. 
We therefore measured Ca
2+ transients that only occurred in 
growth cones (Fig. 2 A). Such local transients have been iden-
tifi  ed in many types of developing neurons, including moto-
neurons, and some of these transients are caused by Ca
2+ infl  ux 
through other channels than VGCCs (Spitzer, 2002). Evidence 
has been presented that the transient receptor potential ion 
  channel 5 (TRPC5) is a channel that can regulate neurite 
growth and growth cone morphology, at least in hippocam-
pal neurons (Greka et al., 2003). Fast Ca
2+ transients, which 
only occur in growth cones but not in proximal axons and cell 
bodies, were barely detectable on laminin-111, neither in Smn
−/−; 
SMN2 nor in control motoneurons at day 5 in culture (Fig. 2 B). 
They were much more frequent on laminin-211/221, both in con-
trol (0.22 ± 0.06 min
−1 on laminin-211/221 vs. 0.04 ± 0.03 min
−1 
on laminin-111) and Smn
−−; SMN2 motoneurons (0.07 ± 0.03 
min
−1 on laminin-211/221 vs. 0.02 ± 0.01 min
−1 on laminin-111; 
Fig. 2 B). In control cultures,  50% of these local transients in 
growth cones could be blocked with CTX (Fig. S1, B and C), 
indicating that VGCCs are also responsible for some but not 
all fast local transients in growth cones of isolated embryonic 
mouse motoneurons. The frequency of these local Ca
2+ tran-
sients was signifi  cantly lower in Smn
−/−; SMN2 motoneurons on 
laminin-211/221 at day 5 in culture (Fig. 2 B, P < 0.05).
Cav2.2 is reduced in axonal growth cones 
of Smn
−/−; SMN2 motoneurons
In embryonic motoneurons, the N-type VGCCs are predomi-
nantly expressed (Urbano et al., 2002; Spafford and Zamponi, 
2003). These channels are located in axon terminals of moto-
neurons where they act as receptors for motor endplate–specifi  c 
forms of laminin (Nishimune et al., 2004). Because embryonic 
cultured Smn
−/−; SMN2 motoneurons showed reduced sponta-
neous Ca
2+ transients in growth cones, we investigated expression 
and cellular distribution of Cav2.2 in control and Smn-defi  cient 
motoneurons (Fig. 3, A–I and M–O) using polyclonal antibodies 
against the α2 chain of this channel. The Cav2.2 signal intensity 
was quantifi  ed as arbitrary units based on quantum levels per 
Figure 1.  Reduced spontaneous Ca
2+ inﬂ   ux into distal 
axons of Smn-deﬁ  cient motoneurons cultured on laminin-
111. (A) Spontaneous Ca
2+ transients in isolated motoneu-
rons were recorded in cell bodies, proximal axons, and 
axonal growth cones. These spontaneous Ca
2+ transients can 
be inhibited by addition of 1 μM TTX or CTX, respectively. 
(B and C) The frequency of spontaneous generalized 
spikelike Ca
2+ transients was determined on day 3 
(n = 51/54), 4 (n = 91/84), 5 (n = 74/84), and 7 (n = 
20/34) from control (Smn
+/+; SMN2) and Smn
−/−; SMN2 
motoneurons on laminin-111. No difference was observed 
in cell bodies and proximal axons (B) of Smn
−/−; SMN2 
motoneurons, but a change was detected in distal axons 
and growth cones (C), ﬁ  rst becoming detectable on day 4 
in culture. (D and E–N) Axon length of cultured motoneurons 
from control and Smn-deﬁ  cient embryos on laminin-111. 
Axon length was measured on day 3 (n = 129/106), 
4 (n = 106/87), 5 (n = 162/206), 6 (n = 59/74), and 
7 (n = 87/115). (D, G–I, and L–N) After day 4, the dif-
ference in axon elongation became signiﬁ  cant. Axons 
of Smn-deﬁ  cient motoneurons did not extend further after 
day 4 in comparison with control cells. Results represent 
the mean ± SEM of pooled data from three independent 
experiments. n, number of motoneurons that were scored in 
total from control or Smn
−/−; SMN2 embryos. *, P < 0.05; 
**, P < 0.001, tested by one-way ANOVA.JCB • VOLUME 179 • NUMBER 1 • 2007  142
pixel per area in cell body, proximal axon, and growth cones. 
A signifi  cantly reduced signal intensity (P < 0.001) was found 
in growth cones of Smn-defi  cient motoneurons (8.7 ± 1.1) ver-
sus controls (21.9 ± 2.1; Fig. 3, C–E). Applying a fi  xation pro-
tocol without detergent and shortened exposure to 4% PFA to 
increase the staining intensity of cell surface–exposed versus 
intracellular Cav2.2, showed this channel to be highly concen-
trated in protrusions of control growth cones (Fig. 3, F and G) 
but not in Smn
−/−; SMN2 growth cones (Fig. 3, H and I). 
Furthermore, Cav2.2 channels colocalize with the active zone 
protein Piccolo, indicating that clusters of Cav2.2 have formed 
active zone-like structures in the growth cone protrusions in 
control motoneurons (Fig. S2, A, C, E, and G, available at 
http://www.jcb.org/cgi/content/full/200703187/DC1). The co-
localization of Cav2.2 with Piccolo was highly reduced in Smn-
defi  cient growth cones (Fig. S2, B, D, F, and H). In control 
motoneurons, these active zone-like structures cover  20% of 
the whole growth cone area. In Smn-defi  cient motoneurons 
<5% of the active zone-like structures are detectable (Fig. S2 I). 
These structures are only found in protrusions but not the core 
or the proximal parts of growth cones and axons (Fig. S2, J–L). 
In contrast to growth cones, the signal intensity in cell bodies of 
Smn
+/+; SMN2 and Smn
−/−; SMN2 motoneurons was not different 
(Fig. 3, A, B, and E).
To analyze whether the reduced Cav2.2 expression in dis-
tal axons is caused by disturbed subcellular distribution of the 
corresponding mRNA, in situ hybridization was performed. 
This experiment did not reveal any difference in cellular distri-
bution or rough differences in expression levels between control 
and Smn-defi  cient motoneurons (Fig. 3, J and K). The specifi  city 
of the in situ hybridization was controlled with a Cav2.2 sense 
probe (Fig. 3 L).
We also applied stimulated emission depletion (STED) 
fl  uorescence microscopy (Dyba and Hell, 2003; Kittel et al., 
2006; Willig et al., 2006) to investigate whether the reduced 
accumulation of Cav2.2 refl  ects a defect in cluster formation of 
this channel. This method enhances the resolution of confocal 
microscopy in the xy axis, so that structures <200 nm that nor-
mally cannot be resolved by classical light microscopy become 
detectable. Intracellular vesicles containing Cav2.2 channels are 
much smaller than the Cav2.2 clusters that form on the cell sur-
face. When we compared the size of the Cav2.2 immunoreactive 
areas in control and Smn
−/−; SMN2 growth cones, it became ap-
parent that in Smn-defi  cient growth cones the relative density of 
large clusters covering an area of at least 0.01 μm
2 versus small 
vesicles is reduced compared with control growth cones (Fig. 3, 
M–O). Collectively, these data suggest that a defect in Cav2.2 
transfer into the cell membrane and active zone-like structures 
in Smn-defi  cient growth cones is responsible for reduced fre-
quency of Ca
2+ transients.
Inhibition of axon elongation 
by laminin-211/221 does not occur 
in Smn
−/−; SMN2 motoneurons
In parallel to Ca
2+ transients, we also analyzed axon elongation 
on laminin-211/221. Mean axon length of control motoneurons 
was 264.1 ± 11.2 μm on laminin-211/221 in comparison to 
335.2 ± 19.0 μm on laminin-111 after 7 d in culture (Fig. 4, 
A, B, and D). Surprisingly, Smn-defi  cient motoneurons did not 
show such a reduction of axon growth on laminin-211/221. 
In contrast, they exhibited a slight but signifi  cant (P < 0.05) 
increase in axon extension (309.2 ± 12.5 μm) in comparison 
with control motoneurons (259.6 ± 10.3 μm) on laminin-211/221 
(Fig. 4, A, C, and E).
We then measured the size of axonal growth cones be-
cause previous studies have shown that the defi  cit in axonal 
β-actin mRNA and protein correlates with reduced axon elon-
gation and growth cone size in Smn
−/−; SMN2 motoneurons that 
were cultured on laminin-111 (Rossoll et al., 2003). The growth 
cone area of Smn-defi  cient motoneurons on laminin-211/221 
did not differ from the area on laminin-111 (Fig. 4, F, H, and J). 
On both substrates, growth cones of Smn
−/−; SMN2 moto-
neurons were smaller than those of Smn
+/+; SMN2 motoneurons 
(Fig. 4, F–J).
Blockade of N-type Ca
2+ channels does 
not reduce axon growth in Smn-deﬁ  cient 
motoneurons
Inhibition of Cav2.2 with CTX blocks global Ca
2+ transients in 
control motoneurons by >80% (Fig. S1 A). In addition, local 
transients that only occur in axonal growth cones are reduced by 
>50%, both at 1 and 0.3 μM CTX, which is considered to be 
highly specifi  c for N-type VGCCs (Fig. S1, A–C). Interestingly, 
the reduction of local transients in growth cones is smaller, 
thus confi  rming earlier observations with Xenopus laevis moto-
neurons that other Ca
2+ channels contribute to rapid local Ca
2+ 
Figure 2.  Decreased frequency of local spontaneous Ca
2+ transients 
in growth cones of Smn
−/−; SMN2 motoneurons on laminin-211/221. 
(A) Local Ca
2+ transients in growth cones (black) were more frequent in Smn
+/+; 
SMN2 motoneurons than in Smn
−/−; SMN2 motoneurons cultured for 5 d. 
(B) The frequency of local spontaneous Ca
2+ transients was signiﬁ  cantly 
higher both for control (n = 34) and Smn-deﬁ  cient motoneurons (n = 39) 
on laminin-211/221 in comparison with laminin-111 (n = 35/42). Despite 
the higher frequency on laminin-211/221, local transients on laminin-
211/221 were signiﬁ  cantly less frequent in Smn-deﬁ  cient motoneurons in 
comparison with controls. Results represent the mean ± SEM of pooled 
data from three independent experiments. n, number of motoneurons that 
were scored in total from control or Smn
−/−; SMN2 embryos. *, P < 0.05 
tested by one-way ANOVA.REDUCED EXCITABILITY IN SMN
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transients in growth cones (Spitzer et al., 2000). To determine the 
role of classical VGCCs for axon growth, we tested whether 
 specifi  c blockade of Cav2.2 with CTX affects axon growth of 
motoneurons in vitro. CTX was applied at 1 μM and a lower 
concentration (0.3 μM) that is considered highly specifi  c for 
N-type VGCCs (Figs. 5 and S1). After 7 d in culture, motoneurons 
grown on laminin-111 or laminin-211/221 were fi  xed and stained 
against tau and microtubule-associated protein 2 to distinguish 
dendrites and axons (Rossoll et al., 2003). 1 μM CTX specifi  cally 
reduces axon growth of control motoneurons on laminin-111 
(335.2 ± 19.0 vs. 240.7 ± 8.5 μm), whereas 0.3 μM CTX was 
less effi  cient (335.2 ± 19.0 vs. 288.2 ± 11.8 μm; Fig. 5 A). 
Axon growth of Smn-  defi  cient neurons on laminin-111 (233.4 ± 
13.8 μm), which was already disturbed, was not further reduced 
both by 1 and 0.3 μM CTX (Fig. 5 A).
We then investigated the effect of 0.3 and 1 μM CTX on 
motoneurons grown on laminin-211/221. Inhibition of Cav2.2 
with CTX led to an increase in axon growth in control motoneu-
rons (Fig. 5 B) at both concentrations. Axon elongation reached 
comparable levels to those seen in motoneurons on laminin-111 
(Fig. 5 A). Smn-defi  cient motoneurons did not show increased 
axon elongation after 0.3 and 1 μM CTX treatments (Fig. 5 B), 
indicating that the response of axonal growth to blockade of 
N-type Ca
2+ channels is lacking in Smn-defi  cient motoneurons. 
Low concentrations (0.3 μM) of CTX showed similar effects as 
1 μM CTX on laminin-211/221, thus providing an argument for 
the specifi  city of the effect for Cav2.2 channels.
In other types of neurons, TRPC3 and 6 have been shown 
to mediate Ca
2+ fl  uxes that modulate axon guidance and neuro-
nal survival in response to brain-derived neurotrophic factor (Li 
et al., 2005; Jia et al., 2007). In addition, TRPC5 activation pro-
motes axon guidance and neurite growth in hippocampal neu-
rons (Greka et al., 2003). Therefore, the possibility exists that 
TRPCs are also involved in the pathological alterations observed 
in Smn-defi  cient motoneurons. Among these candidates, TRPC5 
is highly expressed in embryonic motoneurons. TRPC6 is also 
found but at relatively lower levels, whereas TRPC3 is barely 
detectable (unpublished data). When we analyzed the distribu-
tion of TRPC5 and 6 immunoreactivity in growth cones of control 
and Smn-defi  cient motoneurons, no difference was observed, 
both with respect to subcellular distribution (Fig. S3, A–D, avail-
able at http://www.jcb.org/cgi/content/full/200703187/DC1) 
and signal intensity (Fig. S3, E and F). This led us to conclude 
that alteration in Cav2.2 distribution is responsible for the dif-
ferences in Ca
2+ transients observed in growth cones of Smn-
defi  cient motoneurons.
Figure 3.  Expression and cellular distribution of Cav2.2 pro-
tein and mRNA in primary motoneurons of Smn
−/−; SMN2 
and Smn
+/+; SMN2 embryos. (A–E) Distribution and quantita-
tive analysis of Cav2.2 protein in 7-d-old primary motoneu-
rons of Smn
−/−;  SMN2 and Smn
+/+;  SMN2 embryos on 
laminin-211/221. The signal intensity for Cav2.2 protein in 
the cell body of Smn
−/−; SMN2 motoneurons (A and E; n = 
30) is not reduced in comparison to control cells (B and E; 
n = 30). In contrast, the signal intensity for Cav2.2 is lower in 
axonal growth cones of Smn
−/−; SMN2 motoneurons (D and E; 
n = 30) in comparison to controls (C and E; n = 30). (F–I) 
Cav2.2 immunoreactivity is highly enriched in growth cone 
protrusions in control motoneurons (F and G; n = 25) but not 
in Smn-deﬁ  cient motoneurons (H and I; n = 23) that were 
ﬁ  xed for short time periods and immunostained in the absence of 
detergent to enrich staining of extracellular versus intracellular 
Cav2.2. (J and K) Differences in Cav2.2 mRNA distribution 
are not detected in cell bodies (arrows) and growth cones 
(arrowheads and insets) of motoneurons from Smn
−/−; SMN2 
embryos (n = 35) in comparison to controls (n = 32). (L) The 
speciﬁ   city of the antisense probe was tested with a sense 
Cav2.2 cDNA probe. (M and N) For high-resolution microscopy, 
STED microscopy was applied to reduce the focal spot area 
by one order of magnitude, thus allowing the distinction of 
small vesicle-like structures (arrowheads) from larger areas 
that probably (as discussed in the text) reﬂ  ect clusters at the 
cell surface (arrows). (O) The ratio between vesicles and clus-
ters is increased in Smn-deﬁ  cient motoneurons, caused by a 
signiﬁ  cant reduction of the cluster-like structures in Smn
−/−; 
SMN2 growth cones (N and O) in contrast to growth cones of 
control motoneurons (M and O). Results represent the mean ± 
SEM of pooled data from three independent experiments. 
n, number of motoneurons that were scored in total from con-
trol or Smn
−/−; SMN2 embryos. *, P < 0.05; **, P < 0.001, 
tested by one-way ANOVA and t test, respectively.JCB • VOLUME 179 • NUMBER 1 • 2007  144
8-(4-chlorophenylthio)–3′,5′ cAMP 
(8-CPT-cAMP) enhances SMN protein in 
Smn
−/−; SMN2 motoneurons and restores 
morphological and functional alterations 
in axons
We further tested whether cAMP, which has previously been 
described to enhance the frequency of spontaneous Ca
2+ tran-
sients in developing Xenopus motoneurons (Gorbunova and 
Spitzer, 2002), could enhance the frequency of Ca
2+ transients 
in growth cones of control and Smn-defi  cient mouse motoneu-
rons. Surprisingly, there was only little effect (P > 0.05) in cul-
tured control motoneurons (Fig. 6 A). In contrast, Smn
−/−; 
SMN2 axonal growth cones react with a more than twofold 
increase in the frequency of Ca
2+ transients on day 5 in axon 
terminals after treatment with 100 μM 8-CPT-cAMP. To test 
whether 8-CPT-cAMP has a direct effect on Ca
2+ transients, 
we added CTX together with 8-CPT-cAMP (Fig. S1, C and D). 
Enhanced cAMP does not rescue the reduction of Ca
2+ transients 
that is caused by CTX (Fig. S1 C), indicating that there are 
no CTX-insensitive channels present that open in response to 
8-CPT-cAMP. When we treated Smn
−/−; SMN2 motoneurons 
with CTX, there was little further reduction of local Ca
2+ tran-
sients, but treatment with 8-CPT-cAMP increases Ca
2+ transient 
frequency (Fig. S1 D). This improvement only occurs in Smn
−/−; 
SMN2 but not in control motoneurons, leading to similar levels 
of Ca
2+ transients than those observed with CTX and 8-CPT-
cAMP in control motoneurons (Fig. S1 C). The difference be-
tween control and Smn-defi  cient motoneurons suggests that the 
improvement is not caused by the opening of VGCCs that were 
blocked by CTX treatment, because this increase in Ca
2+ tran-
sients should then occur in both groups and not only in Smn
−/−; 
SMN2 motoneurons.
We then analyzed whether this increase of Ca
2+ transients 
in 8-CPT-cAMP–treated Smn-defi  cient motoneurons correlates 
with increased Cav2.2 expression in Smn-defi  cient growth cones. 
Both the signal intensity of the Cav2.2 staining (Fig. 6, B–D, F, G, 
I, and J) and β-actin in growth cones (Fig. 6, B, C, E, F, H, I, and K) 
was increased to almost normalized levels by this treatment.
The Smn promoter region contains a CreII-binding ele-
ment (Majumder et al., 2004) that mediates cAMP effects on in-
creased SMN2 transcription in mouse hepatocytes. We therefore 
Figure 4.  Axon growth and growth cone morphology of Smn
−/−; SMN2 
motoneurons on laminin-211/221. (A–E) Axon length of control and Smn-
deﬁ  cient motoneurons on laminin-111 and laminin-211/221 after 7 d in 
culture. (A–C) Axons of Smn
−/−; SMN2 motoneurons (n = 210) are shorter 
than those of control motoneurons (n = 93) on laminin-111. (A, D, and E) 
In contrast, axons of Smn
−/−; SMN2 motoneurons (n = 141) extend signiﬁ  -
cantly longer on laminin-211/221. (F–J) Growth cones of Smn-deﬁ  cient 
motoneurons are signiﬁ  cantly smaller both on laminin-111 (F–H; n = 32) 
and laminin-211/221 (F, I, and J; n = 30). Results represent the mean ± 
SEM of pooled data from three independent experiments. n, number of moto-
neurons that were scored in total from control or Smn
−/−; SMN2 embryos. 
*, P < 0.05; **, P < 0.001, tested by one-way ANOVA.
Figure 5.  Axon growth after blockade of Cav2.2. with CTX in Smn
−/−; 
SMN2 and control motoneurons. (A and B) Axon length of 7-d-old isolated 
motoneurons from control and Smn-deﬁ  cient embryos that were grown on 
laminin-111 (A) and laminin-211/221 (B) treated with 1 and 0.3 μM CTX, 
respectively. (A) On laminin-111, control neurons responded to 1 (n = 162) 
and 0.3 μM CTX (n = 186) with reduced axon growth, whereas Smn-
deﬁ  cient cells were unaffected in the presence of both concentrations (n = 151 
for 1 μM and n = 82 for 0.3 μM CTX). (B) On laminin-211/221, CTX-
treatment, both with 1 and 0.3 μM, increases axon extension in control 
motoneurons (n = 99 for 1 μM and n = 59 for 0.3 μM CTX) but not in Smn-
deﬁ  cient neurons (n = 102 for 1 μM and n = 82 for 0.3 μM CTX). Results 
represent the mean ± SEM of pooled data from three independent   experiments. 
n, number of motoneurons that were scored in total from control or Smn
−/−; 
SMN2 embryos. *, P < 0.05; **, P < 0.001, tested by one-way ANOVA.REDUCED EXCITABILITY IN SMN
−/−; SMN2 MOTONEURONS • JABLONKA ET AL. 145
tested whether cAMP up-regulates Smn expression and thus 
restores the morphological and functional alterations in Smn-
defi  cient motoneurons. For this purpose we analyzed Smn protein 
levels and distribution in cultured embryonic motoneurons. 
Because the number of motoneurons that can be isolated from one 
Smn-defi  cient embryo is not suffi  cient for quantitative RT-PCR 
or Western blot analysis, we prepared protein and RNA extracts 
from cultures of E11.5 forebrain neuronal precursor cells from 
control and Smn-defi  cient mice. 100 μM 8-CPT-cAMP increased 
SMN2 mRNA (Fig. S4, A and B, available at http://www.jcb
.org/cgi/content/full/jcb.200703187/DC1) and protein levels by 
 40–100% (Fig. S4 C) in these cells.
Primary motoneurons from Smn
−/−; SMN2 and Smn
+/+; 
SMN2 embryos were treated with 100 μM 8-CPT-cAMP. Both 
in cell bodies, axons, and axonal growth cones, Smn-specifi  c 
fl  uorescence signal intensity was enhanced in Smn-defi  cient 
neurons but not fully restored to control levels (Fig. 7, A–J). 
The reduction of growth cone size is the most prominent patho-
logical feature in cultured Smn
−/−; SMN2 motoneurons (Rossoll 
et al., 2003). 8-CPT-cAMP treatment normalized growth cone size 
in Smn
−/−; SMN2 motoneurons to control levels and CTX did 
not abolish the rescue effect, indicating that it does not involve 
enhanced Ca
2+ transients (Fig. 8, A–E). We then investigated 
whether this effect is caused by a normalization of local β-actin 
levels in distal axons. The ratio of distal to proximal β-actin pro-
tein levels is reduced in Smn
−/−; SMN2 motoneurons (Rossoll 
et al., 2003), and this ratio was normalized by 8-CPT-cAMP (Fig. 
8 F). The altered β-actin ratio is based on increased actin mRNA 
in the growth cone of 8-CPT-cAMP–stimulated Smn-defi  cient 
motoneurons (Fig. 8, G–N). Thus, elevated cAMP increases 
Figure 6.  8-CPT-cAMP treatment restores local Ca
2+ transients and N-type 
Ca
2+ channel (Cav2.2) immunoreactivity in axonal growth cones of Smn
−/−; 
SMN2 motoneurons. (A) Local Ca
2+ transients in growth cones of Smn-
deﬁ  cient motoneurons (n = 30) that were cultured for 5 d on laminin-211/221 
are restored by 8-CPT-cAMP in comparison with controls (n = 30). (B) Quan-
titative analysis of immunoreactivity for Cav2.2 and β-actin in 5-d-old control 
(white bar; n = 30), Smn
−/−; SMN2 (gray bar; n = 30), and 8-CPT-cAMP–
treated Smn
−/−; SMN2 motoneurons (checkered bar; n = 30) cultured 
on laminin-211/221. (C–E) In control motoneurons, Cav2.2 (C and D) and 
β-actin (E) are enriched in axonal growth cones. (F–H) Smn-deﬁ  cient moto-
neurons exhibit reduced Cav2.2 and β-actin accumulation in comparison to 
controls. (B [checkered bar] and I–K) The reduction of signal intensity for 
Cav2.2 and β-actin is restored by 100 μM 8-CPT-cAMP. Results represent the 
mean ± SEM of pooled data from three independent experiments. n, num-
ber of motoneurons that were scored in total from control or Smn
−/−; SMN2 
embryos. *, P < 0.05; **, P < 0.001, tested by one-way ANOVA.
Figure 7.  Smn protein distribution in control and Smn
−/−; SMN2 moto-
neurons after treatment with 8-CPT-cAMP. (A–I) Distribution of Smn protein in 
cell body (A–C), axon (D–F), and growth cones (G–I) of Smn
+/+; SMN2 (A, D, 
and G), Smn
−/−; SMN2 (B, E, and H), and 8-CPT-cAMP–treated Smn
−/−; 
SMN2 (C, F, and I) primary motoneurons cultured for 7 d on laminin-211/221. 
100 μM 8-CPT-cAMP increases Smn immunoreactivity in cell bodies, axons, 
and growth cones of Smn
−/−; SMN2 motoneurons (n = 20 for controls, 
n = 20 for Smn
−/−; SMN2, and n = 20 for Smn
−/−; SMN2 treated with 
100 μM 8-CPT-cAMP). (J) Quantitative analysis of Smn immunoreactivity 
revealed a signiﬁ  cant  Smn increase in 8-CPT-cAMP–treated motoneurons 
(checkered bars) in comparison to untreated Smn
−/−; SMN2 motoneurons. 
Results represent the mean ± SEM of pooled data from three independent 
experiments. n, number of motoneurons that were scored in total from 
control, Smn
−/−; SMN2, or Smn
−/−; SMN2 embryos treated with 100 μM 
8-CPT-cAMP. *, P < 0.05; **, P < 0.001, tested by one-way ANOVA.JCB • VOLUME 179 • NUMBER 1 • 2007  146
distal actin mRNA and protein levels in axons, leading to aug-
mented Cav2.2 levels in growth cones and normalization of Ca
2+ 
transient frequency. Subsequently, we tested whether this effect 
also rescues responsiveness to laminin-211/221 in the Smn
−/−; 
SMN2 motoneurons. As shown in Fig. 8 (O–R), axon length is 
shortened in Smn
−/−; SMN2 neurons on laminin-211/221 when the 
cells are treated with 8-CPT-cAMP, indicating that the respon-
siveness to motor endplate-specifi  c forms of laminin is restored 
by elevated cAMP levels.
Discussion
We have investigated the correlation between defective axon 
elongation and spontaneous excitability in motoneurons from a 
mouse model of SMA. We observed that the reduction of sponta-
neous Ca
2+ transients in distal axons and growth cones is caused 
by defective Cav2.2 accumulation and clustering in the axonal 
growth cones, thus infl  uencing axon growth in the Smn-defi  cient 
motoneurons. These defects can be at least partially compensated 
by 8-CPT-cAMP treatment. Motoneuron disease in SMA, both 
in humans and mouse models, becomes apparent after motoneu-
rons have made contact with skeletal muscle. In a mouse model 
of SMA type I, motoneuron loss is not enhanced during a critical 
period of development when motoneurons depend on trophic 
support from target tissues (Monani et al., 2000). Motoneuron 
numbers are normal at birth, but decrease at postnatal days 3–5. 
During this period, differentiation of motor endplates takes place, 
and we therefore investigated neurons that were cultured on mo-
tor endplate–specifi  c forms of laminin (laminin-211/221). Previ-
ous papers have shown that neurite growth of motoneurons is 
impaired on this substrate (Porter et al., 1995). Furthermore, it has 
been shown that the β2 chain in laminin-221 interacts with the 
pore-forming (Cav) subunit of the N- and P/Q-type–specifi  c VGCC 
(Cav2.2 and Cav2.1; Nishimune et al., 2004), indicating that pre-
synaptic differentiation is mediated through the direct interaction 
of laminin-221 with Cav2.2 channels. Smn-defi  cient motoneu-
rons exhibit a reduced accumulation of Cav2.2 channels in growth 
cones. This fi  nding correlates with reduced Ca
2+ infl  ux and re-
duced spontaneous electrical activity in this part of the neuron.
Gene knockout mice for the laminin β2 chain (Lamb2
−/−) 
or Cav2.1 (Cav2.1
−/−) exhibit strong synaptic maturation defects. 
Lamb2-defi  cient mice develop neuromuscular junction (NMJ) 
degeneration, which is characterized by disturbed active zones 
just after birth (Ino et al., 2001; Nishimune et al., 2004). Cav2.2 
knockout mice do not show any signs of motoneuron disease, 
as the defect can most probably be compensated by Cav2.1 
expression. Cav2.1-defi  cient mice develop normally until the third 
postnatal week (Jun et al., 1999). But from this time point on, 
as in Lamb2
−/− mice, the NMJs degenerate and exhibit a 
decrease of active zone proteins (Nishimune et al., 2004; Fox 
et al., 2007). The delayed disease onset in Cav2.1-defi  cient mice 
can be explained by a compensatory effect of residual Cav2.2, 
which is substituted postnatally by Cav2.1. Altogether, these data 
indicate that the β2 chain interaction of laminin-221 with Cav2.1 
and Cav2.2 supports postnatal development and maintenance of 
NMJs (Nishimune et al., 2004). Our data suggest that the reduced 
Cav2.2 accumulation in the axonal growth cone protrusions of 
Figure 8.  8-CPT-cAMP restores axon elongation, growth cone size, and 
responses to laminin-211/221 in Smn
−/−; SMN2 motoneurons. (A–E) The 
smaller growth cone size of 7-d-old Smn
−/−; SMN2 motoneurons (A and C) 
is rescued by 100 μM 8-CPT-cAMP (A [gray checkered bar] and D) and 
reaches the size of control motoneurons (A, B, and D), also in the pre-
sence of CTX (A and E; n = 30 for each genotype with and without 
100 μM 8-CPT-cAMP). (F) Ratio of β-actin content in the most distal part of 
the axon and the most proximal part of the axon. Smn
−/−; SMN2 motor 
axons (n = 82) show reduced distal β-actin signal intensity in comparison 
to control cells (n = 78). 8-CPT-cAMP treatment of Smn
−/−; SMN2 re-
stores distal β-actin levels (checkered gray bar; n = 90). (G–N) Analysis of 
actin mRNA levels in axonal growth cones by in situ hybridization in moto-
neurons from Smn
−/−; SMN2 (G, I, and L; n = 30), 8-CPT-cAMP–treated 
Smn
−/−; SMN2 (G, J, and M; n = 32), and control embryos (G, H, and K; 
n = 30). (G, J, and M) 8-CPT-cAMP restores the actin mRNA deﬁ  cit in 
axon terminals of Smn
−/−; SMN2 motoneurons. (N) A sense actin probe 
was used as a negative control for the speciﬁ  city of the actin probe. (O–R) 
8-CPT-cAMP also restores the response of Smn
−/−;  SMN2 motor 
axons to laminin-211/221. Axon elongation after 7 d on laminin-211/221 
in control (P; n = 141), Smn
−/−; SMN2 (Q; n = 141) and 8-CPT-cAMP–
treated Smn
−/−; SMN2 (R; n = 60) motoneurons. (O) Quantitative analy-
sis of data. Results represent the mean ± SEM of pooled data from three 
independent experiments. n, number of motoneurons that were scored 
in total from control, Smn
−/−; SMN2, or Smn
−/−; SMN2 embryos were 
treated with 100 μM 8-CPT-cAMP. *, P < 0.05; **, P < 0.001, tested by 
one-way ANOVA.REDUCED EXCITABILITY IN SMN
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Smn-defi  cient motoneurons is responsible for reduced axon 
elongation in cell culture and reduced responsiveness to synapse-
specifi  c laminin isoforms.
Mislocalization of N-type Ca
2+ channels 
in Smn-deﬁ  cient motoneurons on 
laminin-211/221 leads to local excitability 
defects at the growth cone
In patients with SMA, extended neuromuscular latency to elec-
trical stimulation is observed (Krajewska and Hausmanowa-
  Petrusewicz, 2002), pointing to defects in synaptic transmission 
at motor endplates. SMA is a dying-back disease in which the 
degeneration of motoneurons starts at the presynaptic part and 
proceeds backward to the cell body (Cifuentes-Diaz et al., 2002). 
Fly mutants lacking Smn show reduced excitatory postsynaptic 
currents and disorganized synaptic boutons, pointing to defects 
in synaptic function at NMJs (Chan et al., 2003). Such fl  y mod-
els provide further evidence for disturbed actin metabolism 
(Rajendra et al., 2007).
Target-derived signals play a critical role for presynaptic 
differentiation and maintenance during the period when syn-
apses are eliminated and polysynaptic innervation of skele-
tal muscle fi  bers is removed (Nguyen and Lichtman, 1996). 
β2-containing laminin isoforms act as signals for presynaptic 
differentiation (Son et al., 1999). The disturbed presynaptic 
synthesis of β-actin in Smn-defi  cient motoneurons interferes 
with VGCC translocalization to membrane clusters, which, in 
turn, could impair transmitter release from the axon terminals 
(Zhong and Zucker, 2004). Interestingly, other types of Ca
2+ 
channels such as TRPC5 and 6 are not affected. These channels 
do not cluster on growth cone protrusions and are distributed 
more widespread over the growth cone. Moreover, double staining 
with Piccolo, a component of the presynaptic apparatus, revealed 
a severe defect of Cav2.2 accumulation into active zone-like 
structures of Smn-defi  cient motoneurons.
Control motoneurons show reduced axon elongation on 
laminin-211/221 that correlates with increased Ca
2+ spike fre-
quency in axonal growth cones. The contribution of Cav2.2 
accumulation and subsequent enhanced frequency of Ca
2+ tran-
sients to axon elongation on laminin-211/221 becomes evident 
by CTX treatment. Cav2.2 inhibition restores axon elongation 
on laminin-221/211. The lack of response of Smn-defi  cient moto-
neurons to laminin-211/221 could be explained by a massive 
reduction of Ca
2+ transients in the growth cone.
Collectively, we conclude that Smn-defi  cient motoneurons 
are not able to differentiate in response to synapse-specifi  c 
laminins because of their incapability of accumulating Cav2.2 in 
axon terminals. Thus, defective Ca
2+ channel accumulation could 
lead to dysfunction of the active zone (Nishimune et al., 2004), 
and this in turn could lead to disturbed neurotransmitter release 
and thus to degeneration of NMJs.
cAMP compensates for the morphological 
and functional defects in Smn-deﬁ  cient 
motoneurons
We also found that 8-CPT-cAMP restored the defect in excitability 
in axon terminals of Smn
−/−; SMN2 motoneurons. 8-CPT-cAMP 
treatment enhances spontaneous Ca
2+ infl  ux into spinal moto-
neurons of Xenopus oocytes through VGCCs (Gorbunova and 
Spitzer, 2002). In addition, the ratio of cAMP to cGMP has been 
reported to regulate polarity in netrin-1–induced axon guidance 
in Xenopus spinal motoneurons (Nishiyama et al., 2003). The 
enhanced frequency of spontaneous Ca
2+ transients in axonal 
growth cones of Smn
−/−; SMN2 motoneurons correlates with in-
creased Cav2.2 accumulation in growth cones. It appears as if this 
defect is reversed by increased β-actin protein level in distal axons 
of Smn
−/−; SMN2 motoneurons. Thus, our results with 8-CPT-
cAMP could guide the way to new therapeutic strategies for SMA.
Materials and methods
Motoneuron culture
The ventrolateral part of the lumbar spinal cord of E14 embryos was dis-
sected and transferred to HBSS. After 15 min of treatment with 0.05% 
trypsin, cells were triturated and cultured after enrichment by panning with 
antibodies against the mouse p75 neurotrophin receptor (Abcam). Cells 
were plated at a density of 2,000 cells/cm
2 in 4-well dishes (Greiner 
Bio-One) and cultured as described previously (Wiese et al., 1999). The 
culture dishes were precoated with polyornithine and laminin-111 or 
laminin-211/221 (Invitrogen), respectively. 100 μM 8-CPT-cAMP (dissolved 
in HBSS; Calbiochem), 1 μM TTX (Sigma-Aldrich), and 1 or 0.3 μM CTX 
(Sigma-Aldrich), respectively, was added by changing the medium every 
second day.
Forebrain neuronal precursor cell culture
Precursor cells from the forebrain of 11.5-d-old mouse embryos were pre-
pared, and neurospheres were cultured in neurobasal medium with 500 μM 
glutamax (Invitrogen), 50 U/ml penicillin G sodium and 50 U/ml strepto-
mycin sulfate (Invitrogen), B27 (1:50; Invitrogen), and 20 ng/ml EGF and 
bFGF (Cell Concepts).
For Western blot analysis, the neurospheres were plated at high 
density on 60-mm dishes that had been coated with poly ornithine and 
laminin-111. These cells were then grown for 72 h.
Antibodies used for immunocytochemistry
Immunocytochemistry was performed as described previously (Rossoll et al., 
2003). For analysis of membrane-exposed N-type Ca
2+ channels, we ﬁ  xed 
the cells only for 2 min with 4% PFA in 1× TBS without acetone. In addi-
tion, Tween 20 (Sigma-Aldrich) was omitted from all buffers for this set 
of experiments (Fig. 3, F–I). The following primary antibodies were used: 
rabbit polyclonal antibodies against tau at 1 μg/ml (1:1,000; Sigma-Aldrich), 
an N-type Ca
2+ channel (1:200; Sigma-Aldrich), TRPC5 (1:200, Sigma-
Aldrich), and TRPC6 (1:200, Chemicon), mouse monoclonal antibodies 
against 1 g/ml β-actin (Abcam), 1 g/ml microtubule-associated protein 2 
(Sigma-Aldrich), and 2 g/ml Smn (BD Biosciences). Cells were then 
washed three times with 1× TBS-T (20 mM Tris-HCl, pH 7.6, 137 mM 
NaCl, and 0.1% Tween 20) and incubated for 1 h at room temperature 
with Cy2 (1:200)- and Cy3 (1:300)-conjugated secondary antibodies 
(Dianova). The Atto 647N–conjugated secondary antibody (Atto Technology) 
was used for STED microscopy. Confocal images were obtained either with 
a microscope (TCS 4D; Leica) with a 20× 0.5 objective (PL FLUOTAR) or 
a microscope (SP2; Leica) with a 100× 1.4 oil-immersion objective (HCX 
PL APO CS), with identical settings for pinhole and voltage for control and 
Smn-deﬁ  cient motoneurons. For high-resolution microscopy, a STED setup 
mounted to a microscope (SP5; Leica) with a 100× 1.4 oil immersion 
  objective was applied.
Western blot analysis
Forebrain neuronal precursor cells grown on laminin-111 for 72 h were 
collected from the dishes, and protein extraction for Western Blotting was 
performed as described previously (Rossoll et al., 2002). Primary antibodies, 
1 g/ml anti–mouse β-actin antibody (Abcam), 1 g/ml anti–mouse β-III 
tubulin antibody (RDI), and 2 g/ml Smn IgG1 (BD Biosciences) were used.
Calcium imaging
For Ca
2+ imaging analysis, cultured motoneurons were grown on glass 
coverslips. After gently washing in phenol red–free HBSS and permeabili-
zation with 0.25% pluronic F-127 (Sigma-Aldrich) over 5 min, cells were JCB • VOLUME 179 • NUMBER 1 • 2007  148
loaded with 2 μM FURA-2 AM (Invitrogen) at 37°C for 45 min in Ca
2+ and 
Mg
2+ containing HBSS. After washing, coverslips were mounted on a heated 
microscope stage (37°C) and constantly superfused with Ca
2+/Mg
2+-HBSS 
under linear ﬂ  ow conditions.
Measurements were performed by dual-excitation and dual-emission 
ratio imaging using a microscope ﬂ  uorescence measurement workstation 
(Polychrome II; TILL Photonics). Motoneurons were alternately exposed to 
monochromatic light of 340 and 380 nm, and emission was measured at 
512 nm. Real-time microscope imaging was performed using a microscope 
(Axiovert S100TV; Carl Zeiss MicroImaging, Inc.) equipped for epiﬂ  uores-
cence with a dichroid mirror, a 100× 1.3 oil-immersion objective (Fluor; 
Carl Zeiss MicroImaging, Inc.), and a charge-coupled device camera 
(IMAGO; TILL Photonics).
Images were acquired at a frequency of 1 Hz and exposure time 
was 10 ms. The measurements in proximal axons were taken at a distance 
of 10–30 μm from the cell body. Spontaneous Ca
2+ transients (340:380) 
were recorded separately in cell bodies, dendrites, axons, and growth cones 
over a time period of 7.5 min.
Permeabilizing the motoneurons with 20 μM digitonin allowed 
background signal detection after cytosolic dye release for background 
correction. Cells were constantly superfused with Ca
2+/Mg
2+-HBSS over 
the registration time.
In situ hybridization
Hybridization solution containing 3′ biotinylated sense or antisense actin 
or N-type Ca
2+ channel oligonucleotides (200 ng/ml; GeneDetect) was 
applied to the coverslips. Hybridization was performed as described previ-
ously (Rossoll et al., 2003). Images were acquired using a microscope 
(Axiophot; Carl Zeiss MicroImaging, Inc.) equipped with a charge-coupled 
device camera using Axioplan 2 software (Carl Zeiss MicroImaging, Inc.).
RT-PCR from neuronal stem cells
Total RNA from neuronal precursor cells was extracted by Trizol (Invitro-
gen) according to the manufacturer’s protocol, and 1 μg of total RNA was 
used for cDNA ampliﬁ  cation. Ampliﬁ  cation of the SMN2 cDNA was per-
formed with Ex 5f (5′-C  C  A  C  T  T  A  C  T  A  T  C  A  T  G  C  T  -3′) and Ex 8r (5′-C  T  A  C  A  A  C-
A  C  C  C  T  T  C  T  C  A  C  A  G  -3′) primers under the following PCR conditions: 3 min 
at 94°C (1 cycle), 30 s at 94°C, 30 s at 56°C, 45 s at 72°C (30 cycles), and 
5 min at 72°C (1 cycle).
Data analysis
Axons of motoneurons were identiﬁ  ed by their length as processes that are at 
least two times longer than dendrites. Only the longest axonal branches were 
measured. Cultures obtained from mutant and control embryos from different 
litters were analyzed under a microscope (TCS4D; Leica), and axon length 
was measured from pictures using image software (Scion Corporation).
For the quantiﬁ  cation of β-actin and N-type Ca
2+ channel distribu-
tion within the different cellular compartments, the staining intensity in the 
cell body, the proximal and the distal third of the axon, and the growth 
cone were analyzed with AIDA software (Raytest). Background intensity 
was measured for every single picture. The intensity for β-actin and N-type 
Ca
2+ channels was measured as arbitrary units per area, based on quan-
tum levels per pixel, according to the manufacturer’s instructions.
For STED microscopy, LAS AF acquisition software (modiﬁ  ed  by 
Leica) was used. The deconvolution processing was performed with Inspector 
(Max-Planck Institute).
The ﬁ  nal processing of all images was performed with Photoshop 
7.0 (Adobe) and Illustrator 10 (Adobe). Linear contrast enhancement was 
applied to Figs. 1 (E–N), 4 (B–E), and 8 (P–R), and all individual panels 
contained in these ﬁ  gures were treated similarly.
Values from at least three independent experiments were pooled 
and the results were expressed as the mean ± SEM. Statistical signiﬁ  cance 
of differences were assessed by one-way analysis of variance (ANOVA) 
and Bonferroni after testing using Prism software (GraphPad).
Online supplemental material
Fig. S1 shows that Ca
2+ transient frequency is reduced by TTX and CTX in 
cultured motoneurons from 14-d-old mouse embryos. Fig. S2 shows co-
localization of Cav2.2 and the presynaptic protein Piccolo in protrusions of 
axonal growth cones in control and Smn
−/−; SMN2 motoneurons. Fig. S3 
shows distribution and semiquantitative analysis of TRPC5 and 6 immuno-
reactivity in the growth cones of control and Smn-deﬁ  cient motoneurons. 
Fig. S4 shows that 8-CPT-cAMP stimulates SMN2 and Smn transcription 
and increases Smn protein levels in Smn-deﬁ  cient forebrain neuronal pre-
cursor cells. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/200703187/DC1.
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